ResearcherCentral South UniversityNo recent work listed
Xuyang Hou
Matched on OpenAlex author ID A5022983782. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 7
2020: 1 paper · 2021: 2 papers
Papers 3
- HELLS, a chromatin remodeler is highly expressed in pancreatic cancer and downregulation of it impairs tumor growth and sensitizes to cisplatin by reexpressing… Co-author DOI 10.1002/cam4.3627↗
- KDM1A and KDM3A promote tumor growth by upregulating cell cycle-associated genes in pancreatic cancer. Co-author DOI 10.1177/15353702211023473↗
- Downregulation of METTL14 increases apoptosis and autophagy induced by cisplatin in pancreatic cancer cells. Co-author DOI 10.1016/j.biocel.2020.105731↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jun He · 3 shared papers, 2020–2021 · strength 0.41
- Paper KDM1A and KDM3A promote tumor growth by upregulating cell cycle-associated genes in pancreatic cancer. DOI 10.1177/15353702211023473↗
- Paper HELLS, a chromatin remodeler is highly expressed in pancreatic cancer and downregulation of it impairs tumor growth and… DOI 10.1002/cam4.3627↗
- Paper Downregulation of METTL14 increases apoptosis and autophagy induced by cisplatin in pancreatic cancer cells. DOI 10.1016/j.biocel.2020.105731↗
- Leping Yang · 3 shared papers, 2020–2021 · strength 0.41
- Paper KDM1A and KDM3A promote tumor growth by upregulating cell cycle-associated genes in pancreatic cancer. DOI 10.1177/15353702211023473↗
- Paper HELLS, a chromatin remodeler is highly expressed in pancreatic cancer and downregulation of it impairs tumor growth and… DOI 10.1002/cam4.3627↗
- Paper Downregulation of METTL14 increases apoptosis and autophagy induced by cisplatin in pancreatic cancer cells. DOI 10.1016/j.biocel.2020.105731↗
- Yan Zhou · 2 shared papers, 2020–2021 · strength 0.26
- Fanhua Kong · 2 shared papers, 2020–2021 · strength 0.26
- Daming Li · 1 shared paper, 2021 · strength 0.15
- Kunpeng Wang · 1 shared paper, 2021 · strength 0.14
- Xiongying Miao · 1 shared paper, 2020 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.